What is New York Times's earnings per share (EPS)?

New York Times (NYT) reported diluted earnings per share of $2.09 for fiscal year 2025. This represents a 18.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

New York Times Financials

NYT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows New York Times (NYT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 58/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

New York Times has an operating margin of 15.3%, meaning the company retains $15 of operating profit per $100 of revenue. This results in a moderate score of 56/100, indicating healthy but not exceptional operating efficiency. This is up from 13.6% the prior year.

Growth

New York Times's revenue grew 9.2% year-over-year to $2.8B, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

New York Times carries a low D/E ratio of 0.47, meaning only $0.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

New York Times's current ratio of 1.54 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 26/100, which could limit financial flexibility.

Cash Flow

New York Times converts 19.5% of revenue into free cash flow ($550.5M). This strong cash generation earns a score of 74/100.

Returns

New York Times's ROE of 16.9% shows moderate profitability relative to equity, earning a score of 49/100. This is up from 15.3% the prior year.

Altman Z-Score Safe

11.22

New York Times scores 11.22, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($13.5B) relative to total liabilities ($955.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

7/9

New York Times passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.70x

For every $1 of reported earnings, New York Times generates $1.70 in operating cash flow ($584.5M OCF vs $344.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.8B

YoY+9.2%

5Y CAGR+9.6%

10Y CAGR+6.0%

New York Times generated $2.8B in revenue in fiscal year 2025. This represents an increase of 9.2% from the prior year.

EBITDA

$516.6M

YoY+19.0%

5Y CAGR+16.7%

10Y CAGR+10.1%

New York Times's EBITDA was $516.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.0% from the prior year.

Net Income

$344.0M

YoY+17.1%

5Y CAGR+28.0%

10Y CAGR+18.5%

New York Times reported $344.0M in net income in fiscal year 2025. This represents an increase of 17.1% from the prior year.

EPS (Diluted)

$2.09

YoY+18.1%

5Y CAGR+28.4%

10Y CAGR+18.6%

New York Times earned $2.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$550.5M

YoY+44.4%

5Y CAGR+15.9%

10Y CAGR+13.7%

New York Times generated $550.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 44.4% from the prior year.

Cash & Debt

$255.4M

YoY+28.1%

5Y CAGR-2.2%

10Y CAGR+9.2%

New York Times held $255.4M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.72

YoY+38.5%

5Y CAGR+24.6%

10Y CAGR+16.2%

New York Times paid $0.72 per share in dividends in fiscal year 2025. This represents an increase of 38.5% from the prior year.

Shares Outstanding

N/A

Margins & Returns

Gross Margin

50.8%

YoY+1.5pp

5Y CAGR+4.6pp

10Y CAGR-10.1pp

New York Times's gross margin was 50.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the prior year.

Operating Margin

15.3%

YoY+1.7pp

5Y CAGR+5.4pp

10Y CAGR+6.6pp

New York Times's operating margin was 15.3% in fiscal year 2025, reflecting core business profitability. This is up 1.7 percentage points from the prior year.

Net Margin

12.2%

YoY+0.8pp

5Y CAGR+6.6pp

10Y CAGR+8.2pp

New York Times's net profit margin was 12.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.8 percentage points from the prior year.

Return on Equity

16.9%

YoY+1.6pp

5Y CAGR+9.3pp

10Y CAGR+9.2pp

New York Times's ROE was 16.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$264.3M

YoY+6.5%

5Y CAGR+14.7%

New York Times invested $264.3M in research and development in fiscal year 2025. This represents an increase of 6.5% from the prior year.

Share Buybacks

$165.3M

YoY+94.4%

10Y CAGR+9.1%

New York Times spent $165.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 94.4% from the prior year.

Capital Expenditures

$34.0M

YoY+16.5%

5Y CAGR-0.3%

10Y CAGR+2.3%

New York Times invested $34.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.5% from the prior year.

NYT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$2.8B+9.2%	$2.6B+6.6%	$2.4B+5.1%	$2.3B+11.3%	$2.1B+16.3%	$1.8B
Cost of Revenue	$1.4B+6.1%	$1.3B+4.8%	$1.2B+3.3%	$1.2B+16.3%	$1.0B+8.4%	$959.3M
Gross Profit	$1.4B+12.4%	$1.3B+8.4%	$1.2B+7.1%	$1.1B+6.2%	$1.0B+25.6%	$824.3M
R&D Expenses	$264.3M+6.5%	$248.2M+8.5%	$228.8M+12.1%	$204.2M+26.9%	$160.9M+20.6%	$133.4M
SG&A Expenses	$328.1M+6.5%	$307.9M-1.0%	$311.0M+7.5%	$289.3M+15.6%	$250.1M+11.9%	$223.6M
Operating Income	$431.6M+22.9%	$351.1M+27.1%	$276.3M+36.8%	$202.0M-24.6%	$268.0M+52.1%	$176.3M
Interest Expense	N/A	$36.5M+72.9%	$21.1M-48.1%	$40.7M+23.5%	$32.9M+41.2%	$23.3M
Income Tax	$107.3M+19.7%	$89.6M+28.3%	$69.8M+12.5%	$62.1M-12.0%	$70.5M+383.2%	$14.6M
Net Income	$344.0M+17.1%	$293.8M+26.4%	$232.4M+33.6%	$173.9M-20.9%	$220.0M+119.7%	$100.1M
EPS (Diluted)	$2.09+18.1%	$1.77+26.4%	$1.40+34.6%	$1.04-20.6%	$1.31+118.3%	$0.60

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$802.3M+14.5%	$700.8M+2.2%	$685.9M+7.9%	$635.9M-12.5%	$726.6M+13.5%	$640.2M+2.4%	$625.1M+5.2%	$594.0M
Cost of Revenue	$367.2M+5.2%	$349.1M+3.0%	$338.8M+1.2%	$334.6M-1.0%	$338.0M+1.9%	$331.8M+2.8%	$322.8M+1.9%	$316.9M
Gross Profit	$435.1M+23.7%	$351.7M+1.3%	$347.1M+15.2%	$301.3M-22.5%	$388.6M+26.0%	$308.3M+2.0%	$302.3M+9.1%	$277.1M
R&D Expenses	$66.9M-0.2%	$67.0M+4.8%	$63.9M-3.9%	$66.5M+7.7%	$61.8M+1.2%	$61.0M-1.9%	$62.2M-1.5%	$63.2M
SG&A Expenses	$89.0M+16.1%	$76.6M-7.2%	$82.6M+3.3%	$79.9M+5.1%	$76.0M-0.2%	$76.2M-0.9%	$76.9M-2.5%	$78.8M
Operating Income	$161.6M+54.2%	$104.8M-1.7%	$106.6M+81.7%	$58.6M-60.0%	$146.6M+91.1%	$76.7M-3.4%	$79.4M+64.3%	$48.3M
Interest Expense	N/A	N/A	$9.8M-2.2%	$10.0M	N/A	N/A	$8.7M+3.7%	$8.4M
Income Tax	$37.8M+43.4%	$26.4M-8.2%	$28.7M+99.2%	$14.4M-54.8%	$31.9M+52.7%	$20.9M-3.0%	$21.5M+41.4%	$15.2M
Net Income	$129.8M+59.0%	$81.6M-1.6%	$82.9M+67.4%	$49.6M-60.0%	$123.7M+92.9%	$64.1M-2.1%	$65.5M+62.2%	$40.4M
EPS (Diluted)	N/A	$0.500.0%	$0.50+66.7%	$0.30	N/A	$0.39-2.5%	$0.40+66.7%	$0.24

NYT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.0B+5.5%	$2.8B+4.7%	$2.7B+7.1%	$2.5B-1.2%	$2.6B+11.1%	$2.3B
Current Assets	$1.0B+9.8%	$936.3M+19.8%	$781.7M+19.2%	$655.7M-31.2%	$952.7M+14.0%	$835.8M
Cash & Equivalents	$255.4M+28.1%	$199.4M-31.1%	$289.5M+30.8%	$221.4M-30.8%	$320.0M+11.8%	$286.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$290.8M+16.5%	$249.5M+2.9%	$242.5M+11.5%	$217.5M-6.6%	$232.9M+26.8%	$183.7M
Goodwill	$409.2M-0.7%	$412.2M-0.9%	$416.1M+0.5%	$414.0M+148.9%	$166.4M-3.1%	$171.7M
Total Liabilities	$955.7M+4.5%	$914.3M-3.9%	$951.4M+1.7%	$935.8M-8.7%	$1.0B+4.4%	$982.2M
Current Liabilities	$666.7M+8.7%	$613.5M+0.3%	$611.6M+7.1%	$571.2M+2.2%	$559.2M+14.9%	$486.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.0B+5.9%	$1.9B+9.3%	$1.8B+10.3%	$1.6B+3.9%	$1.5B+16.1%	$1.3B
Retained Earnings	$2.6B+9.7%	$2.3B+9.8%	$2.1B+8.1%	$2.0B+6.2%	$1.8B+10.3%	$1.7B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$3.0B+3.8%	$2.9B+2.9%	$2.8B+2.6%	$2.7B-3.7%	$2.8B+2.9%	$2.8B+3.3%	$2.7B+1.9%	$2.6B
Current Assets	$1.0B+9.6%	$938.3M+9.7%	$855.0M+6.7%	$801.6M-14.4%	$936.3M+17.8%	$795.0M+11.0%	$716.2M+5.1%	$681.2M
Cash & Equivalents	$255.4M+2.4%	$249.3M+25.8%	$198.2M+8.6%	$182.6M-8.4%	$199.4M-2.5%	$204.6M-8.2%	$222.9M+7.8%	$206.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$290.8M+42.5%	$204.1M-3.3%	$211.1M+9.6%	$192.5M-22.8%	$249.5M+32.1%	$188.9M+4.2%	$181.3M+2.0%	$177.7M
Goodwill	$409.2M0.0%	$409.2M0.0%	$409.2M-1.3%	$414.8M+0.6%	$412.2M-1.1%	$416.8M+0.6%	$414.2M-0.1%	$414.6M
Total Liabilities	$955.7M+5.4%	$906.9M+4.3%	$869.3M+2.2%	$850.2M-7.0%	$914.3M+0.5%	$910.0M+4.8%	$868.4M-0.7%	$874.9M
Current Liabilities	$666.7M+8.3%	$615.5M+6.5%	$578.0M+4.2%	$554.9M-9.6%	$613.5M+4.1%	$589.6M+8.6%	$543.1M-0.3%	$544.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.0B+3.1%	$2.0B+2.3%	$1.9B+2.7%	$1.9B-2.2%	$1.9B+4.1%	$1.9B+2.6%	$1.8B+3.3%	$1.7B
Retained Earnings	$2.6B+4.1%	$2.5B+2.2%	$2.4B+2.3%	$2.3B+0.9%	$2.3B+4.6%	$2.2B+2.0%	$2.2B+2.1%	$2.1B

NYT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$584.5M+42.4%	$410.5M+13.8%	$360.6M+139.3%	$150.7M-44.0%	$269.1M-9.7%	$297.9M
Capital Expenditures	$34.0M+16.5%	$29.2M+28.7%	$22.7M-38.7%	$37.0M+6.7%	$34.6M+0.5%	$34.5M
Free Cash Flow	$550.5M+44.4%	$381.3M+12.8%	$337.9M+197.2%	$113.7M-51.5%	$234.5M-11.0%	$263.5M
Investing Cash Flow	-$221.3M+27.7%	-$306.1M-91.7%	-$159.7M-117.1%	-$73.6M+59.3%	-$180.8M+9.2%	-$199.1M
Financing Cash Flow	-$306.1M-58.9%	-$192.7M-45.2%	-$132.7M+23.9%	-$174.3M-217.2%	-$54.9M-22.2%	-$45.0M
Dividends Paid	$110.4M+33.2%	$82.9M+19.3%	$69.5M+22.3%	$56.8M+25.3%	$45.3M+18.0%	$38.4M
Share Buybacks	$165.3M+94.4%	$85.0M+90.9%	$44.6M-57.6%	$105.1M	$0	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$164.2M-20.9%	$207.6M+82.7%	$113.6M+14.7%	$99.1M-34.7%	$151.7M+20.9%	$125.5M+56.4%	$80.2M+51.2%	$53.1M
Capital Expenditures	$6.5M-17.1%	$7.9M-23.8%	$10.3M+11.9%	$9.2M+14.6%	$8.1M+14.1%	$7.1M-7.5%	$7.6M+18.8%	$6.4M
Free Cash Flow	$157.6M-21.1%	$199.7M+93.3%	$103.3M+15.0%	$89.9M-37.4%	$143.6M+21.3%	$118.4M+63.1%	$72.6M+55.6%	$46.7M
Investing Cash Flow	-$72.2M+25.6%	-$97.0M-121.8%	-$43.7M-424.5%	-$8.3M+92.3%	-$108.6M-7.2%	-$101.3M-240.1%	-$29.8M+55.1%	-$66.4M
Financing Cash Flow	-$85.4M-44.8%	-$59.0M-8.2%	-$54.5M+49.2%	-$107.3M-123.1%	-$48.1M-13.7%	-$42.3M-25.7%	-$33.7M+51.0%	-$68.7M
Dividends Paid	$29.3M-0.4%	$29.4M-0.7%	$29.6M+34.1%	$22.1M+3.3%	$21.4M-0.5%	$21.5M+0.3%	$21.4M+15.0%	$18.6M
Share Buybacks	$55.5M+103.0%	$27.3M+15.7%	$23.6M-60.0%	$59.0M+138.7%	$24.7M+34.7%	$18.3M+92.1%	$9.5M-70.6%	$32.5M

NYT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	50.8%+1.5pp	49.4%+0.8pp	48.5%+0.9pp	47.6%-2.3pp	49.9%+3.7pp	46.2%
Operating Margin	15.3%+1.7pp	13.6%+2.2pp	11.4%+2.6pp	8.8%-4.2pp	12.9%+3.0pp	9.9%
Net Margin	12.2%+0.8pp	11.4%+1.8pp	9.6%+2.0pp	7.5%-3.1pp	10.6%+5.0pp	5.6%
Return on Equity	16.9%+1.6pp	15.3%+2.1pp	13.2%+2.3pp	10.9%-3.4pp	14.3%+6.7pp	7.5%
Return on Assets	11.5%+1.1pp	10.3%+1.8pp	8.6%+1.7pp	6.9%-1.7pp	8.6%+4.2pp	4.3%
Current Ratio	1.54+0.0	1.53+0.2	1.28+0.1	1.15-0.6	1.70-0.0	1.72
Debt-to-Equity	0.470.0	0.47-0.1	0.54-0.0	0.59-0.1	0.67-0.1	0.74
FCF Margin	19.5%+4.7pp	14.8%+0.8pp	13.9%+9.0pp	4.9%-6.4pp	11.3%-3.5pp	14.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	54.2%+4.0pp	50.2%-0.4pp	50.6%+3.2pp	47.4%-6.1pp	53.5%+5.3pp	48.2%-0.2pp	48.4%+1.7pp	46.7%
Operating Margin	20.1%+5.2pp	14.9%-0.6pp	15.5%+6.3pp	9.2%-11.0pp	20.2%+8.2pp	12.0%-0.7pp	12.7%+4.6pp	8.1%
Net Margin	16.2%+4.5pp	11.7%-0.4pp	12.1%+4.3pp	7.8%-9.2pp	17.0%+7.0pp	10.0%-0.5pp	10.5%+3.7pp	6.8%
Return on Equity	6.4%+2.2pp	4.1%-0.2pp	4.3%+1.6pp	2.6%-3.8pp	6.4%+3.0pp	3.5%-0.2pp	3.6%+1.3pp	2.3%
Return on Assets	4.3%+1.5pp	2.8%-0.1pp	3.0%+1.1pp	1.8%-2.5pp	4.3%+2.0pp	2.3%-0.1pp	2.5%+0.9pp	1.5%
Current Ratio	1.54+0.0	1.52+0.0	1.48+0.0	1.44-0.1	1.53+0.2	1.35+0.0	1.32+0.1	1.25
Debt-to-Equity	0.47+0.0	0.460.0	0.450.0	0.45-0.0	0.47-0.0	0.49+0.0	0.48-0.0	0.50
FCF Margin	19.7%-8.8pp	28.5%+13.4pp	15.1%+0.9pp	14.1%-5.6pp	19.8%+1.3pp	18.5%+6.9pp	11.6%+3.8pp	7.8%

Similar Companies

Pearson PSO

$7.9B

Wiley John & Sons Inc WLY

$1.9B

Wiley (JOHN) & Sons, Inc. WLYB

$2.0B

Gannett Co GCI

$669.3M

Scholastic Corp SCHL

$826.6M

Frequently Asked Questions

What is New York Times's annual revenue?

New York Times (NYT) reported $2.8B in total revenue for fiscal year 2025. This represents a 9.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is New York Times's revenue growing?

New York Times (NYT) revenue grew by 9.2% year-over-year, from $2.6B to $2.8B in fiscal year 2025.

Is New York Times profitable?

Yes, New York Times (NYT) reported a net income of $344.0M in fiscal year 2025, with a net profit margin of 12.2%.

What is New York Times's EBITDA?

New York Times (NYT) had EBITDA of $516.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is New York Times's gross margin?

New York Times (NYT) had a gross margin of 50.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is New York Times's operating margin?

New York Times (NYT) had an operating margin of 15.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is New York Times's net profit margin?

New York Times (NYT) had a net profit margin of 12.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does New York Times pay dividends?

Yes, New York Times (NYT) paid $0.72 per share in dividends during fiscal year 2025.

What is New York Times's return on equity (ROE)?

New York Times (NYT) has a return on equity of 16.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is New York Times's free cash flow?

New York Times (NYT) generated $550.5M in free cash flow during fiscal year 2025. This represents a 44.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is New York Times's operating cash flow?

New York Times (NYT) generated $584.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are New York Times's total assets?

New York Times (NYT) had $3.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are New York Times's capital expenditures?

New York Times (NYT) invested $34.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does New York Times spend on research and development?

New York Times (NYT) invested $264.3M in research and development during fiscal year 2025.

Does New York Times buy back shares?

Yes, New York Times (NYT) spent $165.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is New York Times's current ratio?

New York Times (NYT) had a current ratio of 1.54 as of fiscal year 2025, which is generally considered healthy.

What is New York Times's debt-to-equity ratio?

New York Times (NYT) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is New York Times's return on assets (ROA)?

New York Times (NYT) had a return on assets of 11.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is New York Times's Altman Z-Score?

New York Times (NYT) has an Altman Z-Score of 11.22, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is New York Times's Piotroski F-Score?

New York Times (NYT) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are New York Times's earnings high quality?

New York Times (NYT) has an earnings quality ratio of 1.70x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is New York Times?

New York Times (NYT) scores 58 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.